Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,800 Publications201,349 Funding7,267 Clinical research31

Loading search results…

Browse

Scholars8,800 Publications201,349 Funding7,267 Clinical research31

FiltersClear all

Status

Recruiting14
Not yet recruiting2
Active, not recruiting4
Completed9
Terminated2

Study type

Interventional22
Observational9

Phase

Not applicable13
Not reported9
Phase 43
Phase 12
Phase 1/22
Phase 21

Investigator

Alexander Drelick2
Jana Ivanidze2
Joseph Reginald Osborne2
Timothy McClure2
Anais Rameau1

Show all 28

Department

Medicine14
Radiology10
Anesthesiology1
Obstetrics and Gynecology1
Otolaryngology Head and Neck Surgery1

Condition

Prostatic Neoplasms7
Breast Neoplasms3
Pneumonia, Bacterial2
Adenocarcinoma Of Esophagus1
Anastomotic Leak1

Intervention type

Diagnostic test31
Drug807
Other202
Device190
Biological157
Procedure127

Sponsor type

WCM (investigator-initiated)13
Industry11
Other academic7

Start date

Has results posted5

Diagnostic test×Clear all

Showing 1–20 of 31 studiesSort:

Active, not recruitingInterventional · Not applicableNCT03400215 ↗
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer
Gene KimPI
Intervention
Diagnostic test: Diagnostic Breast Cancer Scan · Diagnostic test: Research Scan for Gradient-echo Spectroscopic Imaging (GSI)
Dates
Jul 2018 – Apr 2026 (est.)

FiltersClear all

Status

Recruiting14
Not yet recruiting2
Active, not recruiting4
Completed9
Terminated2

Study type

Interventional22
Observational9

Phase

Not applicable13
Not reported9
Phase 43
Phase 12
Phase 1/22
Phase 21

Investigator

Alexander Drelick2
Jana Ivanidze2
Joseph Reginald Osborne2
Timothy McClure2
Anais Rameau1

Show all 28

Department

Medicine14
Radiology10
Anesthesiology1
Obstetrics and Gynecology1
Otolaryngology Head and Neck Surgery1

Condition

Prostatic Neoplasms7
Breast Neoplasms3
Pneumonia, Bacterial2
Adenocarcinoma Of Esophagus1
Anastomotic Leak1

Intervention type

Diagnostic test31
Drug807
Other202
Device190
Biological157
Procedure127

Sponsor type

WCM (investigator-initiated)13
Industry11
Other academic7

Start date

Has results posted5

Diagnostic test×Clear all

Showing 1–20 of 31 studiesSort:

Active, not recruitingInterventional · Not applicableNCT03400215 ↗
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer
Gene KimPI
Intervention
Diagnostic test: Diagnostic Breast Cancer Scan · Diagnostic test: Research Scan for Gradient-echo Spectroscopic Imaging (GSI)
Dates
Jul 2018 – Apr 2026 (est.)

Phase 3

Show fewer

Catherine McGuinn1
Conor Liston1
Dana Jeremy Lukin1
Daniel Margolis1
Darshana M Dadhania1
Yuhei Kobayashi1
Eleni Andreopoulou1
Felice H Schnoll-Sussman1
Grant Ellsworth1
Katerina Dodelzon1
Lauren M. Osborne1
Markus Plate1
Mehraneh Dorna Jafari1
Michelle S. Bradbury1
Matthew William McCarthy1
Neel Mehta1
Neil M Khilnani1
Randy Longman1
Robert J. Kim1
Robert J. Kaner1
Robert S. Brown1
Gene Kim1
Scott T. Tagawa1

Show all 9

Show fewer

Pediatrics1
Pharmacology1
Psychiatry1
Surgery1

Show all 44

Show fewer

Anxiety Disorders1
Bacterial Infections1
Barrett Esophagus1
Brain Neoplasms1
COVID-191
Cardiovascular Diseases1
Chronic Pain1
Colitis, Ulcerative1
Coronary Vasospasm1
Cough1
Crohn Disease1
Deglutition Disorders1
Depression, Postpartum1
Disease1
Dysphonia1
HIV Infections1
Hemophilia A1
Hemophilia B1
Hemorrhage1
Hepatitis C1
Infections1
Ischemia1
Meningioma1
Microvascular Angina1
Mood Disorders1
Mycoses1
Obsessive-Compulsive Disorder1
Papillomavirus Infections1
Parasitic Diseases1
Pelvic Pain1
Pneumonia1
Pneumonia, Ventilator-Associated1
Pneumonia, Viral1
Prostatic Diseases1
Salivary Gland Adenoma, Pleomorphic1
Urogenital Neoplasms1
Uterine Cervical Neoplasms1
Virus Diseases1
Vocal Cord Paralysis1

Behavioral

Radiation61

Dietary supplement14

Combination product11

Genetic7

Sponsor

Weill Medical College of Cornell University

Breast Cancer

RecruitingObservationalNCT03784924 ↗

EDRN Prostate MRI Biomarker Study and Reference Set

Timothy McClurePI

Intervention: Diagnostic test: MRI prostate
Dates: Feb 2019 – Jun 2028 (est.)
Sponsor: University of Michigan

PSAProstate Cancer

RecruitingInterventional · Phase 1NCT04167969 ↗

Molecular Phenotyping and Image-Guided Surgical Treatment of Prostate Cancer Using Ultrasmall Silica Nanoparticles

Michelle S. BradburyPI

Intervention: Drug: (64Cu)-NOTA-PSMAi-PEG-Cy5.5-C' dot tracer · Diagnostic test: PET/MRI/fluorescence imaging · Other: Blood and urine sampling · Procedure: laparoscopic radical prostatectomy and bilateral pelvic LN dissection or a salvage lymph node dissection · Drug: 89Zr-DFO-PSMAi-PEG-Cy5.5-C' dots
Dates: Feb 2021 – Nov 2027 (est.)
Sponsor: Memorial Sloan Kettering Cancer Center

Prostate Cancer

Active, not recruitingInterventional · Phase 1NCT04506567 ↗

Phase I/II Dose-escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Joseph Reginald OsbornePI

Intervention: Drug: Multiple Dose of 225Ac-J591 at 45 KBq/kg · Drug: Multiple Dose of 225Ac-J591 at 55 KBq/kg · Drug: Multiple Dose of 225Ac-J591 at 65 KBq/kg · Drug: Fractionated Dose of 225Ac-J591 at 45 KBq/kg · Drug: Fractionated Dose of 225Ac-J591 at 55 KBq/kg · Drug: Fractionated Dose of 225Ac-J591 at 60 KBq/kg · Drug: Fractionated Dose of 225Ac-J591 at 65 KBq/kg · Drug: Fractionated Dose of 225Ac-J591 at 45 KBq/kg (Prior 177Lu-PSMA-RL) · Drug: Fractionated Dose of 225Ac-J591 at 50 KBq/kg (Prior 177Lu-PSMA-RL) · Diagnostic test: 68Ga-PSMA-HBED-CC injection
Dates: Aug 2020 – Jun 2025· Results posted
Sponsor: Weill Medical College of Cornell University

Prostate Cancer

RecruitingObservationalNCT04897282 ↗

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI In-vitro Diagnostics Device to Detect Treatment Response Measured by Endoscopic Healing in Moderate to Severe Ulcerative Colitis Patients Treated With Anti-TNF-a.

Dana Jeremy LukinPI

Intervention: Diagnostic test: UCRI
Dates: Aug 2021 – Dec 2024 (est.)
Sponsor: Glycominds, LLC

Ulcerative Colitis

RecruitingInterventional · Phase 1/2NCT04946370 ↗

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Scott T. TagawaPI

Intervention: Drug: 225Ac-J591 · Drug: Pembrolizumab · Drug: Androgen receptor inhibitor · Diagnostic test: 68Ga-PSMA-11
Dates: Aug 2021 – Oct 2027 (est.)
Sponsor: Weill Medical College of Cornell University

Prostate Cancer

Active, not recruitingObservationalNCT05288361 ↗

Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and No Obstructive Coronary Artery Disease

Yuhei KobayashiPI

Intervention: Diagnostic test: Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire
Dates: Sep 2022 – Dec 2032 (est.)
Sponsor: Yale University

Ischemia and No Obstructive Coronary Artery DiseaseCoronary Microvascular DysfunctionCoronary Vasospasm+3 more

RecruitingInterventional · Phase 1/2NCT05413850 ↗

An Open-label, Multicentre, Integrated Phase 1 & 2 Study to Evaluate the Safety, Tolerability, Radiation Dosimetry and Anti-tumour Activity of Lutetium (177Lu) rhPSMA-10.1 Injection in Men With Metastatic Castrate-resistant Prostate Cancer

Joseph Reginald OsbornePI

Intervention: Drug: Lutetium (177Lu) rhPSMA-10.1 Injection · Diagnostic test: 18F-rhPSMA-7.3 injection (in phase 1 only)
Dates: Jul 2022 – Aug 2026 (est.)
Sponsor: Blue Earth Therapeutics Limited

Prostate CancerMetastatic Castration-resistant Prostate CancermCRPC+3 more

RecruitingInterventional · Not applicableNCT05530343 ↗

A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (The SWAT-BE Study)

Felice H Schnoll-SussmanPI

Intervention: Diagnostic test: Seattle protocol · Diagnostic test: WATS3D brushings
Dates: Oct 2022 – Jun 2026 (est.)
Sponsor: CDx Diagnostics

Barrett EsophagusBarretts Esophagus With DysplasiaEsophageal Adenocarcinoma

RecruitingInterventional · Phase 3NCT05568719 ↗

A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY

Catherine McGuinnPI

Intervention: Diagnostic test: Testing of hepatic AAV Vector integration
Dates: Dec 2022 – Feb 2040 (est.)
Sponsor: Pfizer, Inc.

Hemophilia AHemophilia B

RecruitingInterventional · Not applicableNCT05948657 ↗

ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

Timothy McClurePI

Intervention: Diagnostic test: PSMA-PET CT
Dates: Feb 2024 – Dec 2028 (est.)
Sponsor: Weill Medical College of Cornell University

Prostate Cancer

Active, not recruitingInterventional · Not applicableNCT06002126 ↗

Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries

Grant EllsworthPI

Intervention: Diagnostic test: Xpert HPV · Diagnostic test: QIAsure Methylation Test
Dates: Aug 2023 – Jul 2025· Results posted
Sponsor: Weill Medical College of Cornell University

Cervix CancerHPV InfectionCervical High Grade Squamous Intraepithelial Lesion+1 more

RecruitingInterventional · Phase 4NCT06072807 ↗

Brain [18F]-FES PET/CT in the Diagnosis, Treatment Planning and Response Assessment of Brain Metastases in Patients With Estrogen-Receptor Positive Breast Cancer

Jana IvanidzePI

Intervention: Diagnostic test: Brain Imaging with 18F-FES
Dates: Dec 2023 – Dec 2027 (est.)
Sponsor: Weill Medical College of Cornell University

Breast CancerBrain Metastases

Not yet recruitingInterventional · Not applicableNCT06144294 ↗

Whole-Body Hyperthermia for Mood and Anxiety Disorders

Lauren M. OsbornePI

Intervention: Other: Whole-Body Hyperthermia · Diagnostic test: fMRI
Dates: Jun 2028 – Dec 2031 (est.)
Sponsor: Weill Medical College of Cornell University

Postpartum DepressionMood DisordersAnxiety Disorders+1 more

RecruitingInterventional · Not applicableNCT06168058 ↗

Randomized Controlled, Single-Blinded, Parallel-Group Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices (EMBOLIZE) Trial

Neil M KhilnaniPI

Intervention: Diagnostic test: Transcatheter Venography · Procedure: Bilateral ovarian vein embolization
Dates: Oct 2025 – Jun 2027 (est.)
Sponsor: Weill Medical College of Cornell University

Chronic Pelvic Pain SyndromePelvic PainPelvic Varices+2 more

RecruitingInterventional · Phase 4NCT06377371 ↗

A Pilot Study to Evaluate Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Jana IvanidzePI

Intervention: Diagnostic test: Brain Imaging with [Cu64]DOTATATE · Procedure: Radio-guided Surgery With Neoprobe Utilization
Dates: Sep 2024 – Jan 2027 (est.)
Sponsor: Weill Medical College of Cornell University

Meningioma

RecruitingObservationalNCT06401421 ↗

EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease

Eleni AndreopoulouPI

Intervention: Diagnostic test: ctDNA MRD test
Dates: Jun 2024 – Apr 2030 (est.)
Sponsor: Exact Sciences Corporation

Breast Cancer

Not yet recruitingInterventional · Not applicableNCT06579989 ↗

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures: A Pilot Study

Anais RameauPI

Intervention: Diagnostic test: Ultrasound for cough · Diagnostic test: Ultrasound for vocal fold atrophy or vocal fold paresis/paralysis · Diagnostic test: Ultrasound for dysphagia · Diagnostic test: Ultrasound for dysphonia
Dates: Jan 2027 – Jan 2029 (est.)
Sponsor: Weill Medical College of Cornell University

CoughVocal Cord AtrophyVocal Cord Paresis+3 more

RecruitingInterventional · Not applicableNCT07110636 ↗

A Prospective Randomized Basket Trial Evaluating the Clinical Utility of Plasma-based Microbial Cell-free Metagenomic Sequencing for Diagnosis and Management of Suspected Infections in Adult Immunocompromised Outpatients

Alexander DrelickPI

Intervention: Diagnostic test: Metagenomic plasma-based test for agnostic pathogen detection
Dates: Oct 2025 – Sep 2028 (est.)
Sponsor: Karius, Inc

InfectionInfections, BacterialInfections, Fungal+2 more

RecruitingInterventional · Not applicableNCT07570108 ↗

Precision Functional Mapping to Predict and Track ERP Response in Pediatric Obsessive-Compulsive Disorder: A Longitudinal fMRI Study

Conor ListonPI

Intervention: Behavioral: Exposure and Response Prevention Therapy · Other: Clinical Assessments · Diagnostic test: Research MRI Sessions
Dates: Nov 2026 – Nov 2030 (est.)
Sponsor: Weill Medical College of Cornell University

Obsessive-Compulsive Disorder

‹ Prev1 2 Next ›